#USA #Torrance #chromatography #Phenomenex #Endrix

Phenomenex Introduces Endrix Long Life Columns

In a significant advancement for the scientific community, Phenomenex Inc., a leader in analytical technology and part of the Danaher Corporation, has unveiled the Endrix Long Life LC Columns. This innovative solution promises not only extended durability but also consistent performance in challenging analytical workflows, setting a new benchmark in the chromatography field.

The Endrix Long Life LC Column is specifically engineered to withstand demanding sample matrices and rigorous methodological conditions, enabling laboratories to transition from method development to reproducible results with minimal disruption. This latest evolution in column hardware technology is tailored for laboratories aiming to reduce downtime, enhance throughput, and improve return on investment without compromising chromatographic performance.

Eric Lavold, Vice President of Product Management and Strategy at Phenomenex, emphasized the pressures scientists face today, stating, “Researchers are under consistent pressure to deliver high-quality data while managing the increasing complexity of samples and tighter deadlines. The Endrix Long Life LC has been designed to directly address these challenges by providing outstanding longevity and reliable performance over extended usage.”

The robust design of Endrix Long Life LC Columns protects against common causes of column failure, such as peak distortion, pressure increases due to fouling, and performance drift. By prioritizing the longevity and consistency of their columns, Phenomenex allows laboratories to maintain the integrity of their methods throughout extended analytical phases. This makes Endrix Long Life LC Columns particularly well-suited for pharmaceutical and clinical laboratories, as well as forensic, toxicological, environmental, and food testing labs, where method reliability is paramount.

Phenomenex will officially introduce the Endrix Long Life Columns at the upcoming 73rd ASMS Conference on Mass Spectrometry and Allied Topics (ASMS 2026). Attendees can view application data at booth 802 and engage with Phenomenex specialists regarding best practices for utilizing Endrix technology.

About Phenomenex

Founded with a commitment to innovation, Phenomenex stands as a globally recognized technology company dedicated to providing innovative solutions in analytical chemistry. Their advanced chromatography solutions cater to a wide range of sectors including academia, pharmaceuticals, biotechnology, environmental science, clinical research, regulatory agencies, and industrial labs. From drug discovery to food safety and environmental analysis, Phenomenex’s chromatography technologies propel scientific advancements, aiding researchers in improving public health and well-being.

About Danaher

Danaher Corporation is a leading global innovator in life sciences and diagnostics. The company's commitment is to harness the power of science and technology to enhance human health. Through a connected ecosystem of industry-leading companies, Danaher collaborates closely with customers to tackle their most complex scientific and clinical challenges, expediting innovations from discovery to market, benefiting patients who depend on these advancements.

With about 60,000 associates worldwide, Danaher’s emphasis on continuous improvement and operational excellence drives its mission to create a positive impact on the quality of life globally while working towards a healthier and more sustainable future. For further information about Danaher, visit www.danaher.com.

For more insights and updates from Phenomenex, visit www.phenomenex.com and check out their blog at www.scienceunfiltered.com. Follow them on LinkedIn, Twitter, Facebook, Instagram, and YouTube for the latest news and developments.